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Most alcohol-related driving crashes and fatalities occur at night, at a time 
when many drivers are also partially sleep deprived. Emerging evidence 
indicates that there are similarities in the effects of sleep loss and alcohol on 
behavioral functioning but the combined effects of these factors on driving 
performance are poorly understood. The primary aim of this study was to 
characterize the effects of a low dose of alcohol on driving simulator 
performance during partial sleep loss, using a novel alcohol infusion method 
to minimize between-subject differences in breath alcohol concentration 
(BrAC). Twelve healthy ethnic-Chinese males (23.7 ± 2.3 years old) 
underwent sleep deprivation twice under controlled laboratory conditions, 
during which they performed driving simulator tests and cognitive tasks every 
2-4h. Starting an hour after usual bedtime, subjects were administered alcohol 
(6% ethanol in saline) or placebo (normal saline) intravenously for 2h. During 
alcohol administration, BrACs were maintained at half the legal limit for 
drunk-driving in Singapore (i.e., equivalent to 40mg% in blood). Alcohol 
infusion resulted in a significant increase in variability in lane position and 
speed deviation as compared to placebo (p < 0.05). Self-rated sleepiness levels 
and sedation scores were also higher in the alcohol condition (p < 0.05), 
whereas there was no difference in performance on tasks that assessed 
sustained attention, working memory, divided attention and motor inhibition. 
This study demonstrates that driving simulator performance and sleepiness 
levels are impaired by a low dose of alcohol administered a few hours after 
usual bedtime. In future studies, the alcohol clamp method can be used to 
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further evaluate the interaction of BrAC levels and sleep loss on driving 
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CHAPTER 1. INTRODUCTION 
Vehicular accidents often occur in the late night and early morning hours 
(National Highway Traffic Safety Administration, 1998; Schwing, 1990). Alcohol 
consumption and sleep loss leading to drowsiness are frequently cited as reasons 
(Arnedt, Wilde, Munt, & MacLean, 2001; Dry, Burns, Nettelbeck, Farquharson, 
& White, 2012; Pack et al., 1995) for these accidents, and in today’s society, it is 
increasingly common for these two factors to occur together. However, the 
interactions between alcohol consumption and sleep loss, and their combined 
effects leading to vehicular crashes, are not well researched. Sleep loss and 
alcohol consumption impair functioning of the central nervous system (CNS) and 
individually lead to deficits in neurobehavioral function, alertness, vigilance and 
driving performance (Arnedt et al., 2001; Dry et al., 2012; Pack et al., 1995). 
Recent studies suggest that combining alcohol and sleep loss elicits performance 
impairments that are much greater than those in the presence of either factor alone 
(Banks, Catcheside, Lack, Grunstein, & McEvoy, 2004; Barrett, Horne, & 
Reyner, 2004; Horne, Reyner, & Barrett, 2003). In this body of work, I seek to 
investigate the combined effects of partial sleep loss and a low dose of alcohol on 







1.1 Effects of alcohol consumption on driving and cognition 
Alcohol consumption has rapid dose dependent effects on the nervous 
system, mainly acting through gamma-aminobutyric acid (GABAA) and N-
methyl-D-aspartate (NMDA) receptors in the brain (Vengeliene, Bilbao, 
Molander, & Spanagel, 2008). Alcohol is a non-specific depressant of 
neurological functions (Dry et al., 2012), and a wide range of neurobehavioral 
processes are affected by alcohol intake. Through its actions on the nervous 
system, alcohol impairs driving performance, and is a major cause for motor 
vehicle crashes (Consensus report, 1985).  
 
1.1.1 Effects of alcohol on driving performance 
Epidemiological studies have shown a strong association between alcohol 
and traffic accidents (Borkenstein, 1964; Moskowitz & Fiorentino, 2000; National 
Highway Traffic Safety Administration, 2008; Ramaekers & O’Hanlon, 1994). 
Alcohol-impaired driving crashes accounted for a third of all traffic fatalities in 
the United States in 2012, leading to 10,322 deaths (National Highway Traffic 
Safety Administration, 2014). The negative effects of alcohol consumption on real 
and simulated driving performance have been widely studied (Arnedt, Wilde, 
Munt, & MacLean, 2000; Arnedt et al., 2001; Horne & Baumber, 1991; Roehrs, 
Beare, Zorick, & Roth, 1994). Due to the dangers of driving under the influence 
of alcohol in a real-world setting, most studies have focused on characterizing the 
effects of alcohol on driving performance using a closed driving circuit, or using 
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driving simulators. Driving simulators of different kinds are widely used as they 
provide a controlled environment in which to study the effects of different study 
conditions on driving performance. It is thought that simulated driving has 
ecological validity because driving behaviors such as maintenance of lane 
position and speed are negatively affected by exposure to alcohol, similar to real-
world driving (Shechtman et al., 2009, Winter et al., 2009).  Prior work has shown 
that driver behavior becomes more erratic, in that measures of variability in 
driving performance increase substantially as drivers became more intoxicated 
(Attwood, Williams, & Madill, 1980; Gawron & Ranney, 1988; Kearney & 
Guppy, 1988). Outcome measures associated with driving performance such as 
lane position and velocity are significantly affected by a low dose of alcohol. 
These are frequently assessed measures while studying driving behavior using 
driving simulators. 
 
1.1.2 Effects of alcohol on cognition 
In addition to the well-studied effects of alcohol on driving, alcohol 
modifies general neurological functioning. It affects several neurobehavioral 
domains such as psychomotor functioning (Farquhar, Lambert, Drummond, 
Tiplady, & Wright, 2002; Fillmore & Vogel-Sprott, 1994; Liguori, D’Agostino, 
Dworkin, Edwards, & Robinson, 1999; Nuotto & Korttila, 1991), vigilance 
(Koelega, 1995), response inhibition (Abroms, Gottlob, & Fillmore, 2006; 
Easdon, Izenberg, Armilio, Yu, & Alain, 2005; Fillmore & Vogel-Sprott, 2000; 
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Marczinski & Fillmore, 2003; Mulvihill, Skilling, & Vogel-Sprott, 1997), 
working memory (Boha et al., 2009; Grattan-Miscio & Vogel-Sprott, 2005; 
Kennedy, Turnage, Wilkes, & Dunlap, 1993; Molnar et al., 2009; Paulus, Tapert, 
Pulido, & Schuckit, 2006; Saults, Cowan, Sher, & Moreno, 2007) and divided 
attention (Maylor, Rabbitt, James, & Kerr, 1990; Moskowitz, Burns, & Williams, 
1985; Post, Chaderjian, & Maddock, 2000; Puell & Barrio, 2008; Schulte, Muller-
Oehring, Strasburger, Warzel, & Sabel, 2001). Alcohol also increases drowsiness 
(Landauer & Howat, 1983) and acts as a general depressant of some of the 
functions of the nervous system by increasing GABA inhibitory activity and 
decreasing excitatory NMDA activity (Carta, Mameli, & Valenzuela, 2004; 
Lovinger, White, & Weight, 1989). In addition, alcohol disinhibits self-control 
behavior (Giancola, 2006; Graham, 1980), and its consumption is linked to 
aggression and crimes (Fitzpatrick, 1974; Zeichner & Pihl, 1979). Alcohol shows 
biphasic effects and can elicit both self-reported stimulating and sedative effects 
on individuals. Stimulating effects typically occur during the absorption phase of 
alcohol, at low-to-moderate blood alcohol levels (Pohorecky, 1978). At higher 
concentrations in the bloodstream, alcohol has sedative effects (Pohorecky, 1978). 
The sedative effects of alcohol are partly responsible for the deterioration in 
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0, 55, 75mg% 
 






Boha et al. (2009) 
Grattan-Miscio & 
Vogel-Sprott (2005) 
Kennedy et al. (1993) 
Saults et al. (2007) 
Working 
memory 
0, 15, 30mg% 
0, 64, 73, 80mg% 
 
0, 50, 100, 150mg% 
0, 63, 70, 82, 90mg% 
 
Slower reaction 
times and greater 
errors with 
increasing 
alcohol levels  
Moskowitz et al. 
(1985) 
Puell & Barrio (2008) 
Schulte et al. (2001) 
Divided 
attention 
0, 15, 30, 45, 60 mg% 
 
0, 30, 50 mg% 




increase in error 
rates 
Table 1. Alcohol effects on cognitive performance. 
All studies listed involved oral administration of alcohol. 
 
1.1.3 Blood alcohol content (BAC) levels and Breath alcohol concentrations 
(BrACs) 
Given the dose-dependent effects of alcohol consumption on behavioral 
performance and risk for driving accidents, knowledge of an individual’s blood 
alcohol levels is important. Even though the arterial concentration of alcohol in 
the brain cannot be measured directly, estimation of the general arterial 
concentration, which in turn affects the brain (O'Connor, Morzorati, Christian, & 
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Li, 1998), is useful for law enforcement purposes and for investigating alcohol-
related driving accidents.  
 
After being absorbed by the stomach and small intestine, most alcohol is 
metabolized by the liver. However, small amounts of alcohol are excreted through 
the lungs and this can be measured in the breath. There is a linear relationship 
between blood alcohol content (BAC) levels and breath alcohol concentrations 
(BrAC) (Jones & Andersson, 2003; Wright, Jones, & Jones, 1975). BAC can 
therefore be estimated using a breathalyzer, which is an instrument that measures 
the amount of alcohol in expired breath, i.e. the BrAC. The legal limit for drunk-
driving in Singapore is a BAC of 80mg/dL (i.e., 80mg%, equivalent to 
80mg/210L of breath), similar to the United States and the United Kingdom. 
Other regions in the world have different legal limits in this context, many of 
them lower than this level (Dawson & Reid, 1997; Williamson & Feyer, 2000). In 
spite of these differing legally accepted limits for drunk driving, it has become 
increasingly evident that there are changes in driving and neurobehavioral 
performance at as low as 30mg% BAC, especially when alcohol intake is 
combined with sleep loss (Banks, Catcheside, Lack, Grunstein, & McEvoy, 2004; 






1.2 Effects of sleep deprivation on driving and cognition 
The amount of sleep needed by individuals to maintain optimal daytime 
performance varies, but the average ranges from 7-8.5h per day in a young 
healthy adult (Carskadon & Dement, 2000). Sleep loss occurs when one is 
deprived of this amount of sleep. Regularly getting less than adequate sleep is 
considered as chronic sleep deprivation, whereas a single episode of sudden and 
complete lack of sleep is classified as acute or total sleep deprivation. In 
laboratory studies that investigate the effects of acute sleep loss, participants are 
kept awake for at least 24h, while studies on chronic sleep deprivation usually 
restrict participants’ sleep time to less than 8h (e.g., 5h of time in bed per night), 
over the period of days to weeks (Alhola & Polo-Kantola, 2007).   
 
The daily rhythm of sleep and wakefulness can be conceptualized by a 
two-process mathematical model (Figure 1) (Achermann, Dijk, Brunner, & 
Borbely, 1993; Borbely, 1982). The two processes (Khalsa, Jewett, Duffy, & 
Czeisler, 2000; Van Dongen & Dinges, 2000; Van Dongen & Dinges, 2003) are  
1. The homeostatic sleep process (process S), which is the drive for sleep 
that depends on prior time spent awake, and 
2. The circadian process (process C) which reflects an endogenously 





As time spent awake increases, sleep pressure (process S) increases, which 
then decreases only during subsequent sleep. The circadian rhythm for alertness 
(process C) increases during the biological day and reaches its peak a few hours 
before bedtime. During the night, however, the circadian rhythm of alertness 
decreases and reaches its minimum close to usual wake time. The circadian 
rhythm of sleep is generated by neurons in the suprachiasmatic nucleus (SCN) 
which is the site of the master circadian clock in the hypothalamus. The 
homeostatic sleep process and the circadian process interact to ensure that 
consolidated sleep occurs at night. 
Figure 1. Borbély’s 2-proess model of sleep-wake regulation  
The homeostatic drive for sleepiness (process S) increases throughout the day and 
reaches its maximum near usual bedtime. The circadian drive for alertness (process C) 
increases during the daytime and reaches its peak in the evening, finally dipping near 
bedtime. Shaded areas represent the usual hours of sleep. Figure adapted from Borbély’s 
model of sleep-wake regulation (Borbely & Achermann, 1999). 
 
1.2.1 Effects of fatigue and sleep deprivation on driving performance  
Over 50% of fatal truck crashes are caused by driver fatigue and have 
been estimated to cost $2.7 million per year in the United States ( Leger, 1994). 
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Accident data suggest that driver-related fatigue contributes most strongly to 
vehicular accidents at night (Mackie & Miller, 1978), during the same time 
window when the greatest proportion of alcohol-related fatalities occur. Fatigue is 
usually caused by an extended working period without an adequate period of rest. 
A fatigued person cannot adequately sustain a prescribed level of performance on 
a required task (Dinges, 1995). Another factor that contributes to fatigue, and also 
to impaired driving performance, is sleepiness (National Transportation Safety 
Board, 1999; Dinges, 1995). Sleepiness reflects the drive for sleep and is most 
often the result of sleep deprivation and/or poor sleep quality (Carskadon & 
Dement, 2000; Van Dongen & Dinges, 2000). During the night, fatigue, 
sleepiness and the circadian nadir of alertness can occur concurrently, hence 
resulting in a deterioration in driving performance, especially when driving takes 
place over a prolonged period of time (Mitler et al., 1988; Stutts, Wilkins, Scott 
Osberg, & Vaughn, 2003).  
 
Laboratory evidence shows that the time of day at which people undertake 
a monotonous task, such as continuously driving, is an important factor 
contributing to increased sleepiness (Mavjee & Horne, 1994). The duration of 
driving is equally important (Mavjee & Horne, 1994). Ambulatory 
electroencephalogram (EEG) based studies indicate that alpha and theta power 
density, which are often used as physiological markers of sleepiness, increased 
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towards the end of a long nocturnal driving session (Akerstedt, Kecklund, & 
Knutsson, 1991; Kecklund & Akerstedt, 1993).  
 
In studies using driving simulators, subjective sleepiness and driving 
impairment are positively correlated. Subjects who reported increasing sleepiness 
also had a higher chance of falling asleep behind the wheel, resulting in an 
increased number of driving incidents (Horne & Reyner, 1999; Reyner & Horne, 
1998). Dozens of different metrics of driving performance useful in detecting 
driver drowsiness have been utilized by researchers and though there are no 
published large-scale comparisons, a combination of vehicle speed deviations as 
well as standard deviation of lateral position were shown to be most sensitive to 
driver drowsiness (Forsman et al., 2013). To prevent accidents, there is a need to 
better understand the physiological and behavioral effects of sleep deprivation on 
human driving performance.  
 
1.2.2 Effects of time of day and fatigue  
Many factors including circadian phase, prior wake or extended 
wakefulness, as well as task-related factors can contribute to mental fatigue. The 
effects of circadian rhythms on simulated driving performance have been 
investigated in several studies but often, subjects are asked to remain awake until 
the early morning hours (Lenne, Triggs, & Redman, 1997; Wong, Marshall, 
Grunstein, Dodd, & Rogers, 2008), in which case it is difficult to separate the role 
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of the circadian system from the effects of extended wakefulness. Other studies 
have shown that under sleep restriction, the cost of performance of every hour of 
being awake depended on what the time of day was. It was concluded that the 
factors of circadian phase (driving between 02:00 and 05:00am), prior duration of 
wakefulness, and their interactions become more significant during sleep loss 
which resulted in an increased risk of vehicular accidents, and that these effects 
were mirrored in other studies (Connor et al., 2002; Leger, 1994). 
 
1.2.3 Effects of sleep deprivation on cognition 
Consistent with the negative effects of sleep loss on driving performance, 
sleep deprivation impairs neurocognitive performance and mood (Durmer & 
Dinges, 2005; Van Dongen & Dinges, 2000; Van Dongen & Dinges, 2003). 
Alertness and vigilance, or the state of being ready to respond to factors in the 
environment, are highly sensitive to sleep loss, and individuals consistently show 
slowing of reaction time (RT) and do worse on tests of psychomotor vigilance 
once wakefulness is extended beyond bedtime (Goel, Rao, Durmer, & Dinges, 
2009; Lim & Dinges, 2008).  
 
Sleep loss affects functioning of the prefrontal cortex (PFC) and therefore, 
many tests used in sleep deprivation studies, ranging from simple tests of reaction 
time to more complex higher-order tasks, rely on PFC functioning (Harrison, 
Horne, & Rothwell, 2000; Horne, 1988). The dorsolateral PFC is responsible for 
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attentional control (Durmer & Dinges, 2005) and is required to sustain stimulus 
representations and maintain task-oriented goals (Kane & Engle, 2002). Sleep 
deprivation also affects other cognitive domains, like working memory, which 
requires one to hold and process information in memory stores. Additionally, 
sleep loss makes it difficult to minimize distracting information or the ability to 
remember the order of information (Harrison & Horne, 2000; Horne, 1988; 
Wimmer, Hoffmann, Bonato, & Moffitt, 1992).  
 
Neuroimaging studies have shown that while performing a divided 
attention task during total sleep deprivation (TSD), several brain regions showed 
greater activation correlating with increased subjective sleepiness (Drummond, 
Gillin, & Brown, 2001) assessed outside the scanner, using the Stanford 
Sleepiness Scale (SSS). Motor inhibition assessed by a Go/No-Go task is also 
impaired following sleep deprivation (Drummond, Paulus, & Tapert, 2006). 
Together, these findings demonstrate that sleep deprivation impairs cognitive 
performance and executive functioning. Since driving represents a complex and 
higher-order task with many cognitive aspects involved, impairments in vigilance, 
divided attention, inhibitory control and general psychomotor skills could 





1.3 Effects of alcohol consumption and partial sleep deprivation on driving 
and cognition 
Since consumption of alcohol and lack of sleep are often combined, it is 
important to understand how these factors contribute to deficits in driving and 
cognition. After 17-19h of sustained wakefulness, cognitive performance on 
motor tracking tasks is at a level equivalent to that with a blood alcohol content 
(BAC) of 50mg%, which is the legal limit for driving in many countries (Dawson 
& Reid, 1997; Williamson & Feyer, 2000). Beyond 24h of extended wakefulness, 
performance deteriorated to a level similar to that elicited with a BAC of 100mg% 
(Dawson & Reid, 1997). Other studies comparing the equivalency effects of sleep 
loss with that of alcohol on driving simulator performance have revealed that 
extending wakefulness by 3h can produce deficits in ability to maintain speed and 
road position, comparable to that of a BAC of 50mg% (Arnedt et al., 2001). 
Evidence from recent studies suggest that when sleep loss is combined with low 
doses of alcohol, performance deficits in neurobehavioral function, alertness, 
vigilance and driving are much greater, in comparison with either factor 
considered alone (Howard et al., 2007; Vakulin et al., 2007).  
 
The study by Howard et al demonstrated that combining oral alcohol with 
extended wakefulness impaired performance on a 30-min driving task given a few 
hours after usual bedtime ( Howard et al., 2007). The investigators examined the 
combined effects of a low dose of alcohol (30mg% BAC) with 19h of continuous 
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wakefulness, and found that driving simulator performance was impaired relative 
to performance with no alcohol, and there was an increase in the number of 
crashes and greater variability in speed and lane position during the driving task. 
The study by Vakulin et al investigated the effects of sleep restriction (4h time in 
bed prior to testing) in combination with 2 low doses of alcohol (25mg% and 
35mg% BAC) on daytime driving simulator performance and found an increase in 
steering deviation and crash risk when sleep restriction was coupled with the 
higher dose of alcohol (Vakulin et al., 2007).  
 
1.4 Limitations of prior studies in regards to alcohol administration  
Most of the studies that have involved sleep loss and alcohol employed 
oral ingestion of alcohol as a means of bringing the subjects’ BAC to the intended 
target level for either cognitive testing or driving simulator assessment. In these 
studies, either a standardized volume of alcohol (Howard et al., 2007) was 
administered or the subjects consumed alcohol in proportion to their body weight 
(Vakulin et al., 2007). Breathalyzers were used to measure the breath alcohol 
concentration (BrAC), which reflects the arterial concentration of alcohol 
(O'Connor et al., 1998). However, there are many factors that affect the time 
course and variance of BrACs including sex, age, total body water (TBW), 
hemodynamic status, recent food intake, and drinking history (Martin & Moss, 
1993). In studies that have used oral administration of alcohol to reach target 
BrAC levels in individuals, it is often an issue to maintain and sustain the target 
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BrAC levels during long tasks. Subjects are allowed to consume alcoholic drinks 
and wait for the alcohol to be absorbed and distributed through the blood. To 
overcome the problem of large individual differences in alcohol absorption, 
alternative routes that bypass the gastric absorption and first-pass metabolism, by 
using intravenous infusion of alcohol have been explored (Figure 2) (O'Connor et 
al., 1998). For example, the alcohol clamp method has been developed to 
maintain a target BrAC via intravenous administration (details below), for a 
prolonged duration of time (Ramchandani et al., 2006). In this thesis, I employed 
the alcohol clamp to assess the combined effects of partial sleep loss and alcohol 




Figure 2. BrAC levels following oral vs intravenous administration of alcohol. 
With oral dosing, there is substantial individual variation in absorption rates and peak 
BrAC levels. The alcohol clamp method can be used to minimize between-subject 
differences. 
 
1.5 Thesis scope and hypothesis 
Most alcohol-related accidents happen at night, when drivers are also 
partially deprived of sleep. It is still unclear, however, how alcohol and sleep loss 
specifically interact to impair functioning. What is known is that both factors 
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individually impair performance, and that some of the effects they exert on human 
performance are similar. As both alcohol intake and sleep loss often occur at the 
same time, it is important to understand their combined effects on behavior. This 
study seeks to characterize the effect of a low alcohol dose (40mg%, half the legal 
limit for operating a vehicle in Singapore) on both driving simulator performance 
and cognition during partial sleep loss on young male drivers in Singapore. To 
accomplish this, a sleep deprivation procedure was implemented and carried out 
in a highly controlled laboratory setting to minimize the effects of other 
environmental factors on driving simulator performance. The alcohol clamp 
method was used to minimize inter-subject variability in alcohol absorption and to 
maintain subject BrAC values at 40mg% for about 2 hours. During the alcohol 
infusion, participants completed a battery of cognitive tasks and a 35-min 
simulated night drive. Below, I highlight the primary and secondary aims of the 
thesis project:    
 
Primary aims: 
1. To assess the feasibility of using the alcohol clamp method to study 
the combined effects of alcohol and sleep deprivation on driving 
simulator performance. 
2. To determine whether a low dose of alcohol (40mg% in saline) given 
1-3h after bedtime results in greater deficits in driving simulator 
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performance compared to placebo (saline), as measured by variability 
in lane position and vehicle speed. 
3. To evaluate whether a low dose of alcohol combined with partial sleep 
deprivation results in greater levels of sleepiness compared to placebo, 
as assessed using subjective ratings and ocular measures of 
drowsiness. 
4. To determine whether a low dose of alcohol combined with partial 
sleep deprivation results in greater impairments in sustained attention, 
working memory, and divided attention, as compared to placebo with 
partial sleep deprivation.  
 
Secondary aims: 
1. To determine the duration of sustained wakefulness (without alcohol) 
that results in driving performance impairments comparable to the 
effects of a low dose of alcohol (40mg%) given 1-3h after bedtime. 
2. To evaluate whether alcohol-induced impairments in performance 
persist after the end of alcohol infusion, assessed by keeping 




CHAPTER 2. MATERIALS AND METHODS 
2.1 Subject recruitment  
Healthy ethnic-Chinese males (mean age ± SD = 23.7 ± 2.3 years) were 
enrolled in a laboratory study at the Chronobiology and Sleep Laboratory (CSL), 
Duke-NUS Graduate Medical School Singapore. The rationale for studying young 
males is that this group accounts for the highest proportion of alcohol-related 
driving crashes and fatalities (National Highway Traffic Safety Administration, 
2014). Subjects’ health was assessed using screening questionnaires, and they 
were ineligible if they reported using medications for a health problem or nicotine 
products. Normal colour vision was confirmed using the Ishihara Color Blindness 
Test. Individuals who reported a history of erythema (i.e., an alcohol flushing 
response) following consumption of alcohol were ineligible for the study. 
Individuals with an extreme chronotype (<31 or >69 on the Horne-Östberg 
morningness-eveningness questionnaire, MEQ) (Horne & Ostberg, 1976) or 
Pittsburgh Sleep Quality Index (PSQI) (Buysse, Reynolds, Monk, Berman, & 
Kupfer, 1989) score of  >5 were also excluded (mean ± SD = 1.9 ± 1.2, Table 1). 
Subjects were ineligible if they had a history of shift work or if they travelled 
across at least 1 time zone within 3 weeks prior to the start of the study. All 
subjects held a driver’s license for ≥1 year and reported driving at least once a 
month. Only social drinkers, who drank at least one standard alcoholic beverage 




In the week before the laboratory study, participants were required to 
maintain a fixed daily sleep-wake schedule with 8h of time in bed for sleep from 
11:00pm to 7:00am. Compliance with the sleep schedule was verified by 
actigraphy monitoring (Actiwatch 2, MiniMitter, Inc., Bend, OR). Subjects were 
asked to avoid caffeine and alcohol, and were given a list of common over-the-
counter medications that they had to refrain from consuming (e.g. 
Chlorpheniramine, Robitussin and Tylenol). All study procedures were compliant 
with ethical guidelines for human research outlined in the Declaration of Helsinki. 
Informed written consent was obtained from all participants, and research 
procedures were approved by the SingHealth Centralized Institutional Review 
Board.  
 
2.2 Study Protocol 
A within-subjects design was used to compare the effects of alcohol 
versus placebo on driving simulator performance during a period of sleep 
deprivation. Subjects completed 2 study visits, during which they were 
administered either alcohol or placebo with the order of administration 
randomized and counterbalanced. The minimum washout period between study 
visits was 2 weeks. During each study visit, participants lived individually in a 
controlled laboratory setting for 3 days at the Chronobiology and Sleep 
Laboratory (CSL) in a sound-attenuated suite that was shielded from external time 
cues (Figure 3). Subjects arrived in the evening on the first day and went to sleep 
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at their regular pre-study sleep time (i.e. 11:00pm), which was followed by an 8-
hour sleep opportunity. Subjects were then kept awake for 24 hours in dim 
ambient light of <5 lux, with the exception of driving tasks which were conducted 
in darkness. The suite lights were provided by ceiling-mounted light-emitting 
diode (LED) lamps with illuminance measured at a height of 187cm with an ILT 
1400 radiometer that was fitted with an SEL-033/Y/W detector (International 
Light Technologies, Inc., Peabody, MA) aimed at the brightest point under the 
ceiling lamps. Starting an hour after their usual bedtime (midnight), participants 
were infused with alcohol or placebo for 2h using the alcohol clamp method, 
while performing tasks that assessed driving and neurobehavioral performance 
(see below). Researchers were present at all times to carry out the research 
procedures and to ensure subject compliance. After the sleep deprivation 
procedure, participants were given an 8h sleep opportunity before being 





Figure 3. Study Protocol.  
After an 8-h opportunity for sleep, subjects underwent sleep deprivation for 24h in dim 
lighting. Participants completed two 35-min simulated driving sessions (indicated by 
asterisks), once when they were well rested and once when they were kept awake 2.5h 
after their usual bedtime. Starting at midnight, an infusate solution, either alcohol (6% in 
saline) or placebo (normal saline) was administered intravenously via an infusion pump 
to the subject for approximately 2h (gray bars). 
 
2.3 Alcohol infusion Protocol 
To maintain a prescribed target BrAC, alcohol was administered 
intravenously using the alcohol clamp method. The infusate consisted of 6% 
ethanol in normal saline and was prepared under sterile conditions by the 
Pharmacy Laboratory at Singapore General Hospital. To ensure that the 
concentration of ethanol in saline was approximately 6% v/v, the infusate was 
also tested with a digital refractometer (Palette PR-32α; Atago Co. Ltd., Tokyo). 
Two hours prior to being infused with alcohol or placebo (normal saline), an 
indwelling cannula was inserted into the antecubital vein of the subject’s left arm. 
Participants were administered the infusate using a hospital infusion pump (Alaris 
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IMED Gemini PC-2TX) controlled by a Computer-assisted Alcohol Infusion 
System (CAIS), which is a software platform for implementing the alcohol clamp 
method. Using a pharmacokinetic model of ethanol distribution and elimination, 
the CAIS software is programmed to adjust the infusion rate in order to achieve a 
user-defined breath-alcohol trajectory. The CAIS software adapts the rate of 
alcohol infusion based on breathalyzer measurements taken during the 
experiment, in order to achieve the time course of BrAC prescribed by the 
experimenter. In the present study, following an initial ramp-up period lasting 20 
min, participants’ BAC was clamped at 40mg% for approximately 2h (Figure 4). 
The performance of the clamp was verified by taking frequent breathalyzer 





Figure 4. Computer-assisted alcohol infusion system (CAIS). 
Infusion profile for a representative subject. CAIS first calculates the predicted breath-
alcohol trajectory (red trace in top left panel) and infusion rate (blue trace in bottom left 
panel) according to physical parameters (height, weight and age) of the subject. During 
infusion, breath alcohol concentration (BrAC) levels are measured with a breathalyzer 
(blue dots interspersed among red trace; top right panel) and the infusion rate (blue trace 
in bottom right panel) is adjusted accordingly. Participants were clamped at 0.04g/dL 
(40mg%) for approximately 2h. 
 
 
Figure 5. Setup for infusion system. 
The setup for the infusion system consists of a cannula which was inserted into the left 
antecubital vein of the subject (left panel) and connected to an infusion pump (middle 
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panel), to administer the alcohol solution intravenously. A breathalyzer (right panel) was 




2.4 Assessment of driving and cognition  
2.4.1 Simulated driving tasks  
During each study visit, participants completed 2 simulated driving 
sessions (that lasted 35 min each). The first drive occurred 10.5h after waking 
(5:30pm), and the second drive occurred 2.5h after their usual bedtime (1:30am). 
In addition to the 35-min driving tasks,  shorter driving tasks (13 min each) were 
also used to examine driving performance across different times of the day. Each 
of the driving circuits was built individually using desktop-based driving 
simulator software (Drivesim 5; York Computer Technologies Inc., Kingston, 
ON). The shorter driving circuits consisted of 36 straight road segments and 36 
curved road segments, each ranging from a tight curve made up of one square grid 
to a gradual curve spread out over 6 square grids (Figure 6). All curved road 
segments were joined by a straightaway segment (i.e., one type of curve did not 
immediately follow another; Figure 6). The longer driving circuits were made up 
of 3 short circuits (as described above) joined together (108 curves; Figure 7). 
While driving, subjects were seated in a purpose-built gaming chassis (Obutto 
oZone; Gaming How Pte. Ltd., Singapore) fitted with a steering wheel (Figure 8) 
and foot pedals (Logitech G27; Newark, CA). Participants completed a simulated 
night drive presented on a Dell 27” Ultrasharp monitor (Ultrasharp U2711), and 
all other sources of light in the suite were turned off during driving tasks to mimic 
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nighttime driving conditions without street lights. Data on the Drivesim 5 
simulator program were sampled at a rate of 25Hz throughout all driving sessions. 
 
Subjects were instructed to drive in the left lane of a two-lane road. Lane 
position of the vehicle was calculated as a percentage of the total lane width, with 
50% being in the middle of the left lane, and 0% being the extreme left of the left 
lane and 100% being maximally to the right of the lane. The driving metrics used 
to assess simulated driving performance included the standard deviation of lane 
position (SDLP), the standard deviation of speed deviation from the speed limit 
(SDSD) and the percentage of safe driving time. 
 
Safe driving was defined as the period when the speed deviation of the 
vehicle was within ±10km/h of the prescribed speed limit, and the lateral position 
of the car was within ±25% of the center of the lane. To ensure that participants 
remained motivated to perform their best across all driving sessions, they 
competed for a performance bonus on top of their baseline reimbursement for 
completing all study requirements. A bonus was awarded to 1 out of every 4 
subjects who completed the study. Participants were not informed of the measures 




Figure 6. Curves on driving simulator task. 
The driving simulator task is made up of straightaways and 6 different gradients of 
curves. A tight curve requires a turn to be completed in one square tile of a grid, while a 
gradual curve requires a turn to be completed in six square tiles (in both the x- and y- 
axis) (left panel). Curves are separated by straightaways in the ratio of 1:1, whereby there 
will always be a straightaway leading into a curve, and then followed by a straightaway 





Figure 7. Driving circuits used in driving task. 
Short 13-min drives are made up of 36 curves (left panel) while the long 35-min driving 




Figure 8. Driving simulator setup. 
Participants completed a simulated night drive session seated in a purpose-built gaming 
cockpit. The ambient lights were turned off during the driving task. Subjects were told to 
drive in the left lane of the road at all times.  
 
2.4.2 Neurobehavioral metrics  
In addition to the driving simulator tasks, subjects took cognitive test 
batteries every 2-4h. Tests were implemented using E-Prime 2 software 
(Psychology Software Tools, Inc., PA) and presented on a Samsung 22” Liquid 
Crystal Display (LCD) screen (SyncMaster P2250).   
 
Assessment of Subjective sleepiness and mood 
Neurobehavioral assessment began with subjects rating their sleepiness on 
a 9-point Karolinska Sleepiness Scale (KSS) (Akerstedt & Gillberg, 1990). The 
responses ranged from “very alert (1)” to “very sleepy, great effort to keep awake, 
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fighting sleep (9)” (Figure 9). Participants also completed a visual analog scale 
(VAS) (Babkoff, Caspy, & Mikulincer, 1991) for sleepiness which asked subjects 
to rate how sleepy they felt on a line labelled with the word pair “sleepy” and 
“alert” (Figure 10).  
 
Figure 9. Karolinska Sleepiness Scale (KSS). 
The KSS is a 9-point Likert scale to assess subjective sleepiness.  
 
 
Figure 10. Visual Analog Scale (VAS). 
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The VAS required subjects to rate how they felt along a labelled line with the word pair 
(sleepy-alert) at opposite ends. 
 
 
Assessment of subjective stimulation/sedation 
Subsequently, subjects were asked to complete the brief-biphasic alcohol 
effects scale (B-BAES) (Rueger & King, 2013) in which they were presented with 
a set of 6 words corresponding to the stimulating (“Energized”, “Excited” and 
“Up”) or sedative effects of alcohol (“Sedated”, “Slow thoughts” and “Sluggish”). 
Subjects were asked to rate how they felt using a 7-point scale with responses 
ranging from “not at all (1)” to “extremely (7)” (Figure 11). 
 
Figure 11. Brief-Biphasic Alcohol Effects Scale (B-BAES). 
Subjects had to rate how stimulated or sedated they felt, using a 7-point scale. 
 
Assessment of sustained visual attention  
After completing the subjective scales, subjects completed a 10-min 
psychomotor vigilance task (PVT) which assessed their sustained visual attention 
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performance. During the task, participants maintained their fastest possible 
reaction time to a simple visual stimulus presented at random inter-stimulus 
intervals (1-ms resolution) between 2 and 10 seconds (Dinges & Powell, 1985) 
(Figure 12). PVT lapses were defined as reaction times that exceeded 0.5 seconds 
(Dinges & Powell, 1985). 
 
 
Figure 12. Psychomotor Vigilance Task (PVT). 
The PVT requires subjects to maintain a state of vigilance and wait for a visual counter to 
appear in a rectangle at the center of the screen. Once the visual stimulus is presented and 
starts to count up, subjects had to press a button on the response box as quickly as 
possible. The subject’s reaction time was displayed briefly on the monitor before the start 
of the next trial. 
 
Assessment of working memory 
In addition to sustained attention, subjects’ working memory performance 
was assessed using a visual 2-back (V2B) task. During this task, subjects were 
shown a poker card for 3 seconds on each trial, and they were asked to respond 
whether the card was identical to the one shown 2 cards ago (Figure 13). 
Participants registered their answers using “Yes” and “No” buttons on a response 
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box. Each V2B consisted of 90 trials, and no feedback was given to subjects on 
whether their responses were correct. 
 
Figure 13. Visual 2-Back task (V2B). 
The V2B assessed working memory performance of subjects. The three panels 
correspond to 3 trials in which poker cards were presented one after another. Every time a 
new card was presented e.g. 4 of hearts (1
st
 trial), followed by King of diamonds (2
nd
 
trial) and finally, 4 of hearts (3
rd
 trial), individuals had to decide if it was the same as the 
card that was presented 2 cards before it. In the third trial, since 4 of hearts was shown on 
the first trial, subjects would have to press “Yes”. 
 
Performance testing on motor response inhibition  
Subjects were also tested for their ability to inhibit motor responses using 
the Stop-Signal Task (SST) (Verbruggen & Logan, 2008). During each trial, 
subjects were presented with an arrow that pointed to either the left or right and 
they were instructed to respond as quickly as possible. On a quarter of the trials, a 
‘stop signal’ auditory tone was presented after the arrow was shown and subjects 
were instructed not to respond on these trials (Figure 14). The ‘stop signal’ delay 
interval was adjusted automatically in 50ms increments such that participants 
could successfully stop their response on approximately half of the stop-signal 
trials. The ‘stop-signal’ response time (SSRT) for each session was computed by 
subtracting the stop-signal delay interval from the average response time for trials 




Figure 14. Stop Signal Task (SST). 
The SST requires individuals to wait for an arrow to be presented (either left or right) in 
the middle of the screen. They had to then react accordingly to the direction of the arrow 
by pressing either the left or right button of the response box. On some trials, subjects had 
to inhibit their response when they heard a stop signal tone (auditory beep) after the 
arrow was presented.  
 
Performance testing on divided attention 
Subjects’ capability to perform multiple tasks at the same time was 
assessed using a divided attention task (DAT), which consisted of two 5-min 
blocks. In the first block, participants completed an auditory Go-No-Go (aGNG) 
task, during which they were required to fixate their gaze on a cross in the center 
of the screen (Figure 15) and press a middle button on a response box with their 
left index finger if they heard an even number called (2, 4 or 6), and not respond 
if an odd number was called (1, 3 or 5). Each 5-min aGNG consisted of 30 even 
numbers, 30 odd numbers and 40 presentations of equal-duration silence, 
presented in random order with a fixed inter-stimulus interval of 3 sec. The 
second 5-min block consisted of the same aGNG task, coupled with a visual GNG 
(vGNG) and motor tracking task (MTT). For the vGNG task, subjects were 
instructed to press a button on a trackball with their right thumb if the color of a 
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visually presented square tile changed to orange (Figure 15). The square tile 
changed color every 3 sec, coincident with the auditory stimuli presented during 
the aGNG task. The visual GNG task consisted of 25 orange trials and 75 non-
orange trials (red, blue or green) with a randomized order of presentation. In the 
MTT, subjects were instructed to track the moving square tile with the trackball 
with their right index, middle and ring fingers, while performing the aGNG and 
vGNG tasks at the same time (Figure 15). The square tile moved diagonally at a 
constant rate in 1 of 4 possible directions with the motion path randomized every 
1 to 6 sec, or when the target reached the boundary of the LCD screen. The 
primary outcome measures of the DAT were the error rates and response times on 
the auditory and visual GNG tasks, and the percentage of the time that 
participants failed to keep the cursor on the moving target during the MTT. MTT 
lapses were defined as the percentage of time that the distance between the cursor 
of the trackball and the center of the square exceeded 78 pixels during the entire 










                   
  
Figure 15. Divided Attention Task (DAT). 
The DAT required subjects to complete 3 tasks simultaneously. The auditory Go/No-Go 
(aGNG) required individuals to respond when even numbers were called (top left). 
Subjects had to respond when a square tile turned orange on the visual Go/No-Go 
(vGNG) task (top right), and finally a motor tracking task (MTT) as shown in bottom 
panel, whereby they had to track the motion of the square tile using a trackball. The 
dotted black arrow at the bottom panel indicates a random path of the tile, and there was 
no such indication during the actual task.  
 
2.4.3 Other metrics 
Eyelid closure monitoring 
Subjects’ sleepiness was assessed objectively during the PVT by 
monitoring percentage eyelid closure over the pupil over time (PERCLOS). The 
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vertical diameter of the left pupil was recorded by infra-red pupillography at 120 
Hz using a head-mounted eye-tracker that was worn by the subjects like a visor 
(ISCAN, INC., Woburn, MA). PERCLOS was defined as the percentage of time 
that at least 80% of the pupil was covered by the eyelid (Dinges, Mallis, Maislin, 
& Powell, 1998).  
 
Polysomnography (PSG)  
In order to rule-out potential differences in baseline sleep between study 
visits accounting for differences in performance, polysomnographic activity was 
recorded during baseline sleep episodes. The electroencephalogram (EEG), 
electro-oculagram (EOG) and electromyogram (EMG) were recorded using the 
standard International 10-20 system for electrode placement  (Figure 16) (Iber, 
Ancoli-Israel, Chesson, & Quan, 2007) All signals were bandpass-filtered online 
(EEG and EOG at 0.3 to 35 Hz, EMG at 10 to 100 Hz), and recorded at 200 Hz 
using a Comet Portable EEG system from Grass Technologies (Astro-Med, Inc., 
West Warwick, RI). The EEG was recorded from the frontal (F3-A2, F4-A1), 
central (C3-A2, C4-A1) and occipital (O1-A2, O2-A1) derivations; the EOG was 
recorded from electrodes placed either slightly above (right) or below (left) the 
outer canthus of both eyes, and referenced to the contralateral mastoid electrode 
(A1 or A2) and each derivation was averaged online to obtain a single mastoid-
referenced channel, and the EMG was recorded with electrodes placed on the chin 




Figure 16. 10-20 system for EEG placement. 
Recommended placement for EEG electrodes as put forth by American Academy of 
Sleep Medicine (AASM). Adapted figure (Iber, Ancoli-Israel, Chesson, & Quan, 
2007). 
 
2.5 Data Analysis 
2.5.1 Actigraphy measurement 
Actigraphy data were used to assess sleep behavior in the week prior to 
the laboratory study. The wrist-worn Actiwatch 2 collected actigraphy data every 
minute, which was subsequently analyzed using Actiware 5 software. The time-
in-bed for sleep for each subject was circumscribed by participants’ sleep diaries, 
while sleep onset was defined as the start of the first 5-min block of epochs 
whereby all but one epoch was scored as immobile. In a similar fashion, sleep 
offset was defined as the end of the last 5-min block of epochs whereby all but 




The total sleep time (TST) was calculated as the duration of scored sleep 
from onset of sleep to sleep offset, while sleep efficiency (SE) was defined as 
TST divided by the amount of time-in-bed for sleep. The amount of sleep and 
sleep efficiency were averaged across the entire week prior to the laboratory study 
for each subject. Actigraphy data from 2 subjects were not available for analysis 
due to technical problems with the Actiwatch device and/or software, and these 
individuals were admitted to the study on the basis of their sleep-wake diaries.  
 
2.5.2 Sleep Staging and EEG spectral analysis. 
The PSG recordings during baseline sleep were outsourced for sleep 
staging to The Siesta Group (The Siesta Group Schlafanalyse GmbH, Vienna, 
Austria). Sleep was staged in non-overlapping 30-sec epochs according to 
guidelines established by the American Academy of Sleep Medicine (Iber, 
Ancoli-Israel, Chesson, & Quan, 2007). Several standard sleep staging parameters 
were analyzed, including total sleep time, sleep efficiency (TST divided by time-
in-bed for sleep), the number of awakenings, latency to the first occurrence of N2 
sleep, latency to the first occurrence of rapid eye movement (REM) sleep, minutes 
spent in each of the sleep stages (N1, N2, N3, and REM), and the amount of time 
spent in each sleep stage relative to TST.  
 
EEG spectral power was analyzed in running 4-sec epochs that overlapped 
by 2 sec. During each epoch, EEG spectral power was estimated using FFT 
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analysis with a Tukey window. Epochs that contained artifacts were identified and 
removed using an algorithm based on spectral power thresholds (The Siesta 
Group Schlafanalyse GmbH). As in prior work, slow-wave activity (SWA) in 
non-rapid-eye-movement (NREM) sleep was used as a marker of homeostatic 
sleep pressure (Borbely, Baumann, Brandeis, Strauch, & Lehmann, 1981). To 
assess the time course of SWA EEG during baseline NREM sleep, data were log-
transformed and reduced by averaging in 60 min, non-overlapping bins in the 0.75 
to 4.5 Hz range.  
 
2.5.3 Driving Simulator Data 
The Drivesim 5 software provided data on lane position, speed deviations, 
and safe driving behavior. For all driving sessions, data was excluded from when 
the drive initially began to where the first speed limit sign was observed, since 
subjects would have to accelerate from a standstill at the beginning. The standard 
deviation of lane position (SDLP) was assessed across the entire driving session, 
and calculated based on the distance of the center of the vehicle from the center of 
the lane. The standard deviation of speed from the posted speed limit (SDSD) was 
also calculated across the entire driving session. The amount of “safe” time was 
measured as a percentage of total driving time to determine the amount of “safe” 





2.5.4 PERCLOS measurement 
To assess drowsiness objectively, eye-tracking data recorded during the 
PVT sessions were used for determining percentage eyelid closure over the pupil 
over time (PERCLOS), as previously described (Dinges, Mallis, Maislin, & 
Powell, 1998). The first and last minutes of the PVT were excluded from the 
analysis as described in previous work (Chua et al., 2012; Chua et al., 2014). The 
baseline pupil diameter was measured during the first 3 PVT sessions when 
participants were rested. Eye closure events were identified as periods when the 
pupil vertical diameter value was less than 20% of the baseline diameter, i.e. 
when at least 80% of the pupil was covered by the eyelid (Dinges, Mallis, 
Maislin, & Powell, 1998).  
 
2.5.5 Statistical comparisons 
For measures that were taken once per study visit (e.g., pre-study 
actigraphy and baseline sleep staging data), a paired Student t-test (2-tailed 
distribution) was used to compare behavior between conditions (alcohol versus 
placebo visits). Normality of data was tested using the Shapiro-Wilk test. In cases 
where the data did not exhibit a normal distribution, non-parametric (Wilcoxon 
Signed-Rank test) statistics were employed. EEG spectral power in NREM sleep 
was log-transformed and compared between study visits in 1-h time bins using 
analysis of variance (ANOVA) with repeated measures. EEG slow wave activity 
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assessed in NREM sleep across the entire sleep episode was analyzed between 
study visits using a paired 2-tailed t-test.  
 
The primary measures of interests included driving simulator performance 
(SDLP, SDSD, and % safe driving time), neurobehavioral performance (response 
times and error rates) and physiological results (PERCLOS) during alcohol and 
placebo infusion. The main driving sessions used for comparison between alcohol 
and placebo infusion were the 35-min sessions taken at 18.5h after wake. Subjects 
also carried out 35-min driving sessions at 10.5h during rested wake (RW), and 
this was considered as baseline performance. Paired comparisons (Wilcoxon 
Signed-Rank test) were performed on the differences during infusion from 
baseline performance, in both conditions.  
 
During each study visit, participants completed a total of 7 cognitive test 
sessions and 8 driving simulator sessions (6 short driving tasks and 2 long driving 
tasks). The first 13-min of the 35-min driving sessions was used to form a total of 
8, 13-min driving sessions across each study visit. Performance was compared by 
carrying out two-way repeated measures ANOVA using visit (alcohol or placebo) 
and time since wake (TSW), to assess whether differences in driving performance 
were specific to the infusion time point alone, or if behavioral differences were 
present at other time points as well (e.g., at baseline or after the infusion). In cases 
where a significant interaction was observed, multiple comparison testing was 
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performed using the Bonferroni method. Statistical significance for all measures 
was based on a threshold of α = 0.05. Statistics were performed using SigmaStat 




CHAPTER 3. RESULTS 
3.1 Subject demographics and pre-study actigraphy 
Twelve subjects met our eligibility criteria and completed all study 
requirements (Table 1). There were 6 individuals who were excluded before the 
start of the laboratory protocol, including 4 subjects who dropped out of the study 
due to other commitments and 2 subjects who were excluded because they did not 





MEQ PSQI BMI 
(kg m-2) 




A 22 41 2 22.7 1 2 35 
B 22 55 3 22.9 1 2 42 
C 28 62 0 20.5 1 2 21 
D 22 51 2 24.5 1 2 28 
E 26 44 0 24.3 2 1 23 
F 22 50 2 23.5 2 1 21 
G 26 39 3 21.3 2 1 42 
H 21 47 3 23.2 1 2 21 
I 21 56 3 24.8 2 1 71 
J 24 45 0 22.3 1 2 21 
K 24 58 2 24.6 2 1 14 
L 26 39 3 20.5 2 1 21 
Table 2. Characteristics of subjects who completed all study requirements. 
BMI, body mass index; MEQ, Horne- ̣Östberg Morningness-Eveningness questionnaire; 
PSQI, Pittsburgh Sleep Quality Index. 
 
Prior to each laboratory visit, participants were required to keep to a 
regular sleep schedule from 11pm to 7am to ensure that subjects were well rested 
and had similar sleep history before they underwent sleep deprivation in the 
laboratory. Table 2 shows that subjects’ sleep behavior was similar prior to each 
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study visit. Actigraphy results indicate that subjects slept approximately 7h and 
40min per night in the week prior to each laboratory visit. 
 
 






95% CI t P 
Bedtime 
(hh:mm) 
23:01 (0:10) 23:00 (0:10) 0:00 -0:00 to 0:00 0.33 0.75 
Wake time 
(hh:mm) 
7:09 (0:11) 7:07 (0:08) 0:01 -0:00 to 0:05 1.08 0.31 
Time in bed 
(h) 
8.1(0.2) 8.1(0.2) -0.02 -0.1 to 0.14 0.40 0.70 
Total sleep 
time (h) 








94.1(2.9) 93.7(3.4) 0.39 -2.11 to 2.89 0.35 0.73 
Awakenings 
(No.) 
5.6(4.7) 7.0(5.4) -1.36 -2.63 to -0.09 -2.42 0.04 
Table 3. Pre-study sleep behavior assessed by diaries and actigraphy 
During pre-study screening, bedtime, wake time, and time in bed were determined by 
sleep diary. Total sleep time, sleep efficiency, sleep onset latency, and the number of 
awakenings were estimated using actigraphy. There were no differences in pre-study 
sleep history for between study visits.  
 
3.2 Baseline sleep EEG measurement 
Baseline sleep EEG and staging were analyzed during the first night of 
each study visit, in order to ensure that participants exhibited similar sleep 
architecture prior to undergoing sleep deprivation in the alcohol and placebo 
conditions. As summarized in Table 3, there were no differences in amount of 
time spent in N1, N2, N3 and REM sleep across both study visits. Next, the time 
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course of SWA in NREM baseline sleep was examined and it was found that there 
was no difference in the time course of SWA prior to the start of the sleep 
deprivation episodes (Figure 17A). The distribution of spectral power from 0.25-
16 Hz in NREM sleep was also examined and found to be similar between alcohol 
and placebo study visits (Figure 17B). SWA in NREM sleep across the frontal, 
central and occipital derivations for the entire sleep episode was also analyzed and 
there was no difference between the alcohol and placebo study visits (Figure 
17C). Together, these results suggest that the baseline sleep physiology was 
similar across study visits. Therefore, differences in neurobehavioral outcomes 
during infusion of alcohol versus placebo cannot be attributed to differences in 
sleep quality or sleep architecture prior to sleep deprivation. 
 
Figure 17. Slow-wave activity (SWA) in NREM baseline sleep. 
(A) Slow-wave activity in NREM sleep during baseline 8h sleep episodes. Black traces 
show SWA for the placebo condition while the blue traces show the EEG activity for the 
alcohol condition. The mean ± SEM is shown. (B) EEG spectral power in NREM sleep 
during baseline sleep in 0.25 Hz frequency bins. (C) EEG spectral power in SWA NREM 
sleep in the frontal, central and occipital regions during baseline sleep episodes.  












95% CI t P 
Time in bed 
(min) 477.8(3.8) 479.1(2.3) -1.29 
-4.11 to 
1.53 -1.01 0.33 
Total sleep 
time (min) 448(10.8) 449.1(11.9) -1.13 
-11.52 to 
9.27 -0.24 0.82 
Sleep 
efficiency 
(%) 93.8(2.1) 93.8(2.6) 0.02 
-2.11 to 
2.14 0.02 0.99 
WASO (min) 17.4(9.5) 18.8(12) -1.38 
-10.37 to 
7.62 -0.34 0.74 
No. of 
awakenings 17.3(5.8) 18.5(7.9) -1.25 
-4.79 to 
2.29 -0.78 0.45 
Latency N1 
(min) 12.4(9.8) 11.2(5) 1.21 
-2.86 to 
5.28 0.65 0.53 
Latency N2 
(min) 15.3(9.5) 14.3(4.9) 1.08 -2.93 to 5.1 0.59 0.56 
Latency N3 
(min) 24.3(9.9) 23.0(7) 1.29 
-3.85 to 
6.43 0.55 0.59 
Latency REM 
(min) 94.8(35.6) 91.1(26.3) 3.67 
-20.35 to 
27.68 0.34 0.74 
N1 (min) 34.9(10.5) 33.5(8.6) 1.42 
-3.97 to 
6.81 0.58 0.57 
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N2 (min) 176.7(29.8) 172.2(34.4) 4.50 
-6.89 to 
15.89 0.87 0.40 
N3 (min) 108.5(36.7) 112.8(34.9) -4.21 
-13.67 to 
5.25 -0.98 0.35 
REM (min) 127.9(21.3) 130.7(27.4) -2.83 
-15.13 to 
9.46 -0.51 0.62 
N1 (%TST) 7.8(2.5) 7.5(2.1) 0.32 
-1.04 to 
1.68 0.52 0.61 
N2 (%TST) 39.4(6.4) 38.4(7.7) 1.07 
-1.42 to 
3.55 0.94 0.37 
N3 (%TST) 24.3(8.3) 25.1(7.7) -0.84 
-2.49 to 
0.82 -1.12 0.29 
REM 
(%TST) 28.5(4.4) 29.1(5.8) -0.55 
-3.11 to 
2.01 -0.47 0.65 
Table 4. Sleep architecture during baseline sleep. 
During each study visit, subjects were given an 8h baseline sleep opportunity from 
11:00pm to 7:00am. There were no differences in sleep staging results between study 
visits. For all measures, the mean ± SD is shown.  
 
3.3 Breath alcohol concentration (BrAC) during clamped infusion 
Breath alcohol concentration (BrAC) values of the 12 subjects taken 
during alcohol infusion showed that they were successfully maintained at a BrAC 
of 0.04g/dL (40mg%) for approximately 2h (Figure 18). With alcohol clamping, a 
pre-drive BrAC level of 38 ± 2 mg% and a post-drive mean BrAC level of 41 ± 3 




Figure 18. Breath alcohol concentration (BrAC) values. 
BrAC values of subjects (n = 12) during the alcohol infusion. Participants were clamped 
at 0.04g/dL (40mg%) for approximately 2h. Darkened area represents the 35-min driving 
task. 
 
3.4 Effects of alcohol on driving performance 
3.4.1 Standard deviation of lane position (SDLP) 
Subjects completed two 35-min driving sessions during each visit, one 
after 10.5 h of wakefulness and the other after 18.5 h of wakefulness during the 
alcohol or placebo infusion (Figure 3). Subjects became more variable in their 
lane positioning during the alcohol infusion as compared to the placebo condition 
(Figure 19, Figure 20).  In 11 out of 12 participants, the increase in SDLP during 
the alcohol infusion relative to baseline was greater than in the placebo condition 
(Figure 20B). Relative to baseline driving performance, the median increase in 
variability in lane position was nearly 3-fold higher (Table 5) during infusion with 





Figure 19. Lane position of vehicle during infusion with alcohol versus placebo. 
For a representative subject, lane position is shown across a 35-min simulated driving 
task during infusion with placebo (left) versus alcohol (right). A greater number of high-




Figure 20. Standard deviation of lane position (SDLP) during infusion. 
(A) shows the SDLP measure of individual subjects during baseline (10.5h after wake) 
and partial sleep deprivation (18.5h after wake). (B) shows the individual increase in 
SDLP in 11 of 12 subjects during infusion of alcohol versus placebo and (C) shows that 
variability in lane position increases by a greater amount during alcohol versus placebo 
infusion.  
 
3.4.2 Standard deviation of speed from speed limit (SDSD) 
In addition, it was more difficult for subjects to keep to the stipulated speed limit 
during the alcohol infusion as compared to the placebo condition (Figure 21,Table 
5). Based on the median difference in SDSD relative to baseline, variability in 
speed was nearly 7-fold higher in the alcohol condition (0.92km/h) relative to 
administration of placebo (0.13km/h, p = 0.009). 
 
Figure 22. Standard deviation of speed from speed limit (SDSD) performance during 
infusion.  
(A) Shows the SDSD during the baseline (10.5h after wake) and partial sleep deprivation 
(18.5h after wake). (B) shows the individual increase in SDSD in 11 of 12 subjects 
during infusion of alcohol versus placebo and (C) shows that variability in speed 




3.4.3 Safe driving time (%) 
Consistent with results for SDLP and SDSD, exposure to alcohol resulted 
in a reduction in safe driving time (Figure 23), and 11 out of 12 subjects 
performed worse in the alcohol condition relative to placebo (Figure 24). The 
median decrease in safe driving time was about 5 times greater during exposure to 





Figure 23. Unsafe driving time during infusion with alcohol versus placebo. 
Black horizontal bars show unsafe driving events. For a representative subject, (A) lane 
position and (B) unsafe driving time are shown across a 35-min simulated driving task 




Figure 24. Amount of safe driving time (%) during infusion. 
(A) Shows the percentage of safe driving time during baseline (10.5h after wake) and 
partial sleep deprivation (18.5h after wake). (B) shows the decrease in safe driving time 
in 11 of 12 subjects during infusion of alcohol versus placebo and (C) shows that safe 
driving time decreased by a greater amount during alcohol versus placebo infusion. 
 
 








ΔSDLP (%) 1.62 (0.19 to 3.59) 6.61 (2.59 to 8.54) 2.667 0.005 
ΔSDSD (km/h) 0.13 (-0.07 to 0.53) 0.92 (0.54 to 2.30) 2.510 0.009 
ΔSafe driving time 
(%) 
-1.70 (-5.15 to -0.55) -8.81 (-15.85 to -3.96) -2.746 0.003 
Table 5. Statistical summary for driving simulator measures during infusion. 
IQR, Interquartile range; SDLP, Standard deviation of lane position; SDSD, Standard 
deviation of speed deviation from speed limit. Measures are based on the difference 
between baseline and sleep deprivation. 
 
3.5 Effects of alcohol on cognition and physiological measures of drowsiness 
To compare the effects of alcohol versus placebo on performance across 
different cognitive tasks, paired comparisons were performed for behavioral tests 
taken during the infusion. Alcohol significantly increased self-rated sleepiness on 
the KSS and scores on the B-BAES–sedated scale (Table 6) as compared to the 
placebo condition. By comparison, there were no differences between alcohol and 
placebo for sleepiness on the VAS, B-BAES-stimulated scale, DAT mean 
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reaction time, MTT lapses, PVT lapses, PERCLOS, V2B error rate and SSRTs 
(Table 6).   
 








KSS 4.50 (4.00 to 6.50) 6.00 (5.00 to 7.00) 2.203 0.023 





2.67 (2.00 to 3.75) 2.83 (1.50 to 3.92) -0.134 0.898 
B-BAES Sedated 2.50 (1.08 to 3.58) 3.67 (2.42 to 4.75) 2.347 0.014 
DAT aGNG 
mean log RT 
(ms) 
2.95 (2.88 to 3.01) 2.92 (2.88 to 3.03) 0.078 0.970 
MTT Lapses (%) 0.02 (0.00 to 0.62) 0.61 (0.05 to 1.27) 0.866 0.432 
PVT Lapses 
(No.) 
5.50 (3.00 to 10.75) 5.50 (1.25 to 15.25) 0.225 0.831 
PERCLOS (%) 2.70 (1.05 to 11.40) 1.48 (0.21 to 9.15) -0.800 0.465 
V2B error rate 
(%) 
4.44 (2.22 to 10.00) 6.70 (1.94 to 11.39) 1.138 0.266 
SSRT (ms) 183.93 (168.69 to 199.52) 184.05 (169.04 to 
228.10) 
-0.078 0.970 
Table 6. Statistical summary for subjective, neurobehavioral and physiological measures 
during infusion. 
IQR, Interquartile range; KSS, Karolinska sleepiness scale; VAS, Visual analog scale; B-
BAES, Brief bi-phasic alcohol effects scale; DAT, Divided attention task; MTT, Mouse 
tracking task; PVT, Psychomotor vigilance task; PERCLOS, Percentage eyelid closure 
over the pupil over time; V2B, Visual 2-back task; SSRT, Stop-signal response time. 






3.6 Effects of sleep loss on driving simulator performance 
In addition to the two 35-min driving tasks that were given during each 
study visit, participants completed six 13-min driving tasks across the sleep 
deprivation protocol. To investigate the effects of alcohol and increasing time 
awake on driving performance, the time-course of performance on the 13-min 
drives was examined, including the first 13-min of the longer driving sessions that 
occurred 10.5h and 18.5h after wake. ANOVA was used to evaluate whether 
differences in driving performance between study visits were specific to the time 
point at which alcohol was administered. For SDLP, there was a significant 
interaction between study visit and time since wake (F7,77 = 2.31, p = 0.034). 
Based on multiple comparisons testing, SDLP was significantly different only at 
18.5h after wake (t = 3.47, p < 0.001; Figure 25; Table 7), such that variability in 
lane position was greater during infusion of alcohol versus placebo. The other 
driving measures did not show a significant interaction between study visit and 
time since wake, whereas there was a main effect of time awake such that all 




Figure 25. Driving performance during 13-min sessions across time. 
Driving performance deficits increased over time spent awake, as shown by the increase 
in variability in lane positioning, deviation from speed limit and decrease in safe driving 
time. (A) shows the individual profiles of the subjects on the 3 measures of interest while 
(B) shows the group-averaged data. Post hoc analysis shows that the increase in 
variability of SDLP performance of subjects during alcohol infusion at 18.5h after wake 
is similar to performance in the placebo condition at 22.5h after wake. The decrease in 
safe driving time during alcohol infusion was comparable to that of 20.5h after wake on 
the placebo condition.  
SDLP, Standard deviation of lane position; SDSD, Standard deviation of speed from 
speed limit 
 
 Time Since wake Visit Effects Time Since Wake 
x Visit Effects 
Measure F P F P F P 
SDLP (%) 19.653 <0.001 0.330 0.577 2.319 0.034 
SDSD (km/h) 7.011 <0.001 2.098 0.175 1.560 0.160 
Safe driving time 
(%) 
10.586 <0.001 0.0534 0.822 1.417 0.211 
Table 7. Statistical summary for driving performance across time. 




3.7 Equivalency of effects of alcohol and sleep deprivation on driving 
measures 
In a post hoc analysis, SDLP in the alcohol condition (first 13 min of the 
drive, see Figure 25) was compared with simulated driving performance during the 
sessions following the placebo infusion. It was found that SDLP measured 18.5h 
after wake during infusion with alcohol was significantly worse than SDLP 
performance at 20.5h after wake with placebo (t11 = 2.56, p = 0.026) but 
comparable to performance at 22.5h after wake during infusion with placebo (t11 
= 0.22, p = 0.83). Hence the degree of impairment caused by alcohol at 18.5h 
after wake was equivalent to an additional 2-4h of sleep deprivation in the 
placebo condition (See Figure 25).  
 
3.8 Effects of sleep loss on cognition and physiological measures 
Next, the interaction between study visit (alcohol visit versus placebo 
visit) and time since wake was examined for subjective ratings, cognitive 
performance and PERCLOS. As summarized in Table 5, scores on the KSS and 
B-BAES sedated scale were higher during the infusion of alcohol versus placebo. 
To evaluate whether this difference was specific to the time point that alcohol was 
infused, ANOVA was performed to compare behavioral measures across all time 
points. For both the KSS and B-BAES sedated scale, a significant interaction was 
observed between study visit and time since wake (Table 8). Based on multiple 
comparison testing, KSS scores were significantly higher in the alcohol condition 
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only during administration of alcohol (t = 2.84, p = 0.006), whereas subjects felt 
significantly more sedated not only during the alcohol infusion (t = 3.94, p < 
0.001), but also at the next time point (t = 4.34, p < 0.001). The only cognitive 
performance measure that showed a significant interaction between study visit 
and time since wake was the V2B error rate, with a higher error rate observed in 
the alcohol condition 19.5h after wake, i.e., after the end of the alcohol infusion (t 
= 2.50, p = 0.015). As expected, there was a significant main effect of time since 
wake on all measures (with the exception of SSRT), such that subjects felt 
sleepier and performed worse with increasing exposure to sleep deprivation 
(Figure 26-Figure 29).  
 
Figure 26. Subjective measures with increasing time awake. 
Results for self-assessed sleepiness and subjective feelings are shown across 24h of 
extended wakefulness.  During sleep deprivation, subjects showed an increase in self-
rated sleepiness on the (A) KSS and (B) VAS, (C) a decrease in feeling stimulated, and 
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(D) an increase in feeling sedated. The gray bars indicate times when alcohol or placebo 
was infused intravenously.   
KSS, Karolinska sleepiness scale; B-BAES, Brief bi-phasic alcohol effects scale. 
Asterisks (*) represent significant differences between study visits due to alcohol. 
 
 
Figure 27. Divided attention performance across extended wakefulness. 
Results for mean reaction time and lapses in tracking in the divided attention task are 
shown across 24h of extended wakefulness. During sleep deprivation, subjects showed 
(A) an increase in auditory reaction times on a Go/No-Go task taken alone (red) and 
while performing a visual Go/No-Go task and motor tracking task simultaneously (black 
traces), and (B) an increase in lapse time on a motor tracking task The gray bars indicate 
times when alcohol or placebo was infused intravenously.   
 
Figure 28. Sustained attention and eye closures during sleep deprivation. 
Results for the lapses on psychomotor vigilance task (PVT) and percentage of eyelid 
closure are shown across 24h of extended wakefulness.  During sleep deprivation, 
subjects showed (E) an increase in lapses in sustained attention and (B), an increase in 
eye closures. The gray bars indicate times when alcohol or placebo was infused 
intravenously.   






Figure 29. Working memory and motor inhibition performance during sleep deprivation. 
Results for the visual 2-back task and stop-signal task are shown across 24h of extended 
wakefulness.  During sleep deprivation, subjects showed (A) an increase in error rate on a 
working memory task, but the change in stop-signal response time (SSRT) did not reach 
statistical significance. The gray bars indicate times when alcohol or placebo was infused 
intravenously.   
V2B, Visual 2-back Task; SSRT, Stop-signal response time. Asterisks (*) represent 





 Time Since wake Visit Effects Time Since Wake 
x Visit Effects 
Measure F P F P F P 
KSS 36.133 <0.001 1.109 0.315 2.294 0.045 
VAS 25.785 <0.001 0.895 0.504 0.766 0.400 
B-BAES 
Stimulated 
18.840 <0.001 0.758 0.403 0.258 0.954 
B-BAES Sedated 12.213 <0.001 9.991 0.009 3.709 0.003 
DAT Audio 
mean log RT 
(ms) 
28.370 <0.001 0.701 0.420 1.074 0.387 
MTT Lapses (%) 3.591 0.004 0.486 0.500 1.341 0.252 
PVT Lapses 
(No.) 
23.576 <0.001 0.339 0.572 0.836 0.547 
PERCLOS (%) 3.912 0.004 1.939 0.209 0.884 0.521 
V2B error rate 
(%) 
9.284 <0.001 0.031 0.864 2.640 0.024 
SSRT (ms) 0.862 0.527 1.501 0.192 0.091 0.768 
Table 8. Statistical summary of neurobehavioral and physiological measures across time. 
KSS, Karolinska sleepiness scale; B-BAES, Brief bi-phasic alcohol effects scale; PVT, 
Psychomotor vigilance task; DAT, Divided attention task; MTT, Mouse tracking task; 
PERCLOS, Percentage eyelid closure over the pupil over time; V2B, Visual 2-back task; 




CHAPTER 4. DISCUSSION 
The results in this study demonstrate that combining a low dose of alcohol 
with partial sleep loss significantly impairs driving simulator performance. At a 
BrAC of only half the legal limit for drunk-driving in Singapore (40mg%), 
driving performance was substantially worse than in the placebo condition, and 
participants exhibited higher levels of self-rated sleepiness and  sedation. This 
study has real-world relevance, as alcohol-related crashes occur most frequently 
at night when individuals are also partially sleep-deprived. The degree of 
impairment caused by alcohol was equivalent to an additional 2-4h of sleep loss, 
i.e. equivalent to staying awake for more than 21 hours. Together, these findings 
suggest that in the presence of sleep deprivation, a low dose of alcohol can have 
deleterious effects on driving performance in some individuals.  
 
4.1 Effects of combining alcohol and sleep deprivation 
4.1.1 Driving performance 
In the present study, it was found that alcohol combined with partial sleep 
loss resulted in an increase in the standard deviation of lane position (SDLP), an 
increase in the standard deviation of speed deviation from posted speed limit 
(SDSD), and an overall decrease in the amount of safe driving time. These 
findings are consistent with previous studies that have examined driving simulator 
performance in response to alcohol and partial sleep loss (Banks et al., 2004; 
Barrett, Horne, & Reyner, 2004; Horne, Reyner, & Barrett, 2003; Vakulin et al., 
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2007). For example, an earlier study showed that, following a night of partial 
sleep deprivation (5h of time in bed on the previous night), a low dose of alcohol 
(35mg% BAC)  significantly increased steering deviation and the number of 
crashes, assessed during a driving simulator task taken at 1:00am (Banks et al., 
2004).  
 
In another study which investigated sleep restriction (4h time in bed prior 
to testing) in combination with 2 low doses of alcohol (25mg% and 35mg% BAC)  
on daytime driving simulator performance found a 33% increase in steering 
deviation and 6-fold increase in crash risk when sleep restriction was coupled 
with the higher dose of alcohol (Vakulin et al., 2007). Both of these studies used a 
70-min driving task, however, and BrAC levels decreased substantially during the 
simulated drive. By comparison, the alcohol clamp procedure was used in the 
current study to ensure that the BrAC was maintained at the prescribed target 
level. Consistent with findings reported here, another study has demonstrated that 
combining oral alcohol with extended wakefulness can impair performance on a 
30-min driving task given a few hours after usual bedtime (Howard et al., 2007).  
 
For example, it was shown that a low dose of alcohol (30mg% BAC) 
combined with 19h of continuous wakefulness impaired driving simulator 
performance relative to performance with no alcohol, and there was an increase in 
the number of crashes and greater variability in speed and lane position during the 
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driving task (Howard et al., 2007). In another study that compared the 
equivalency effects of sleep loss and alcohol on driving simulator performance, it 
was reported that extending wakefulness by ~3h produced impairments similar to 
that of a BAC of 50mg% when well rested (Arnedt et al., 2001). These results are 
analogous to the present study, in which the SDLP at a BrAC of 40mg% was 
equivalent to an extra 2-4h of sleep deprivation in the placebo condition.   
 
4.1.2 Subjective behavioral measures 
In the present study, participants rated themselves as feeling sleepier and 
more sedated during infusion with alcohol as compared to placebo. Even in well-
rested individuals, ingestion of alcohol can increase subjective sleepiness due to 
the depressant effects of alcohol on the CNS (Finnigan & Hammersley, 1992). 
Consumption of alcohol has been shown to reduce sleep latency for daytime naps 
and nighttime sleep (Carskadon et al., 1986; MacLean & Cairns, 1982).  It should 
be noted, however, that alcohol consumption can lead to biphasic effects, with a 
stimulatory effect during alcohol absorption, followed by sedative effects during 
the elimination phase (Pohorecky, 1978). The subjects in this study did not report 
any increase in stimulatory feelings, but felt significantly more sedated in the 
presence of alcohol. The sedative effects of alcohol likely accounted for higher 





4.1.3 Objective behavioral measures 
In contrast to results for subjective measures, performance on 
neurobehavioral tests did not show additional decrements due to the presence of 
alcohol, and objective drowsiness (measured by PERCLOS) was similar in the 
alcohol and placebo conditions. In contrast to results reported here, a previous 
study found that a low dose of alcohol with extended wakefulness (30mg% BAC 
at 19h after waking) resulted in slower PVT response times and an increase in 
attentional lapses (Howard et al., 2007). Another study compared the effects of 
alcohol (BAC of 20mg%, 40mg% and 90mg%) versus sleep loss (0, 2, 4, 6 and 
8h) on psychomotor vigilance, memory and divided attention. It was found that 2h 
of sleep loss was equivalent to a BAC of 45mg% on the PVT and divided 
attention task (Roehrs, Burduvali, Bonahoom, Drake, & Roth, 2003). 
 
The effects of alcohol on divided attention may depend on the complexity 
of the task, as some studies (in rested subjects) have suggested that performance is 
impaired starting from as low as 15mg% (Moskowitz et al., 1985), whereas other 
studies did not find deficits in divided attention for BAC levels ranging from 30-
50mg% (Puell & Barrio, 2008). Similarly, working memory performance has 
been shown to be impaired at 48mg% BAC on the Self-Ordered Pointing Task, 
but no deficits were observed in another study that used a similar working 
memory task at BACs of up to 100mg% (Peterson, Rothfleisch, Zelazo, & Pihl, 
1990; Pihl, Paylan, Gentes-Hawn, & Hoaken, 2003). While alcohol consumption 
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is known to result in behavioral disinhibition (Halpern-Felsher, Millstein, & 
Ellen, 1996; Zeichner & Pihl, 1979), deficits in motor inhibition were not 
observed at a BrAC level of 40mg% in the present study. It is possible that the 
alcohol dose used was insufficient to cause impairment, as previous studies have 
demonstrated deficits in motor inhibition at a target BrAC level of 80mg% 
(Abroms, Fillmore, & Marczinski, 2003; Fillmore & Vogel-Sprott, 2000). The 
differences in the effects of alcohol on performance across studies could be 
related to differences in experimental conditions and the types of tasks that were 
used. It should also be highlighted that the size and magnitude of alcohol-induced 
impairment differs across different domains of cognitive processing, even when 
tested in the same set of individuals (Dry et al., 2012). 
 
As summarized above, driving performance was impaired during the 
infusion of alcohol, whereas performance on several cognitive tasks was similar 
to performance in the placebo condition. This results was surprising, as driving is 
a complex behavioral task that requires sustained attention, the ability to divide 
attention across tasks (e.g., monitor speed and steer the vehicle), and motor 
inhibition, all of which were tested during infusion with alcohol. Since the driving 
task was much longer (35 min) relative to the other performance tasks, it is 
possible that the driving performance measures were more sensitive to alcohol 
and sleep deprivation due to time-on-task effects. Also, because the driving task 
started about an hour after the onset of the neurobehavioral test battery, 
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participants were sleep-deprived by an additional hour, which may have 
contributed to greater deficits in driving simulator performance. 
 
4.2 Inter-individual variability in driving performance  
Previous studies have shown that there are large individual differences in 
cognitive vulnerability to sleep deprivation (Rupp, Wesensten, & Balkin, 2012; 
Van Dongen, Baynard, Maislin, & Dinges, 2004). In the present study, there were 
relatively small individual differences in driving performance in the placebo 
condition for the simulated drive that occurred a few hours after usual bedtime 
(Figure 20, Figure 22 and Figure 24). In the presence of alcohol, however, 
between-subject differences in driving performance appeared to increase. While 
most participants showed small decrements in performance, there were 2 
individuals (subjects H and J) who appeared to be especially vulnerable to the 
effects of alcohol. It is possible that these subjects were less motivated to perform 
well after consuming alcohol, but it should be highlighted that all subjects 
competed for a bonus based on their driving performance. Since the alcohol 
clamp method was implemented, these differences cannot be explained by 
between-subject individual differences in alcohol absorption or BrAC levels, but 
rather could reflect increased susceptibility to alcohol caused by partial sleep loss. 
In future studies, these possibilities can be explored by comparing between-
subject differences in driving simulator performance during the daytime when 
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subjects are well rested, versus during the night when participants are exposed to 
partial sleep deprivation.  
 
4.3 Advantages and disadvantages of the alcohol clamp method 
All prior studies that have examined the effects of alcohol and sleep 
deprivation on driving simulator performance have used oral administration of 
alcohol (Banks et al., 2004; Howard et al., 2007; Vakulin et al., 2007). A major 
limitation of oral dosing is that alcohol levels can change substantially across a 
long-duration driving task, in which case it can be difficult to interpret the effects 
of a specific dose of alcohol on performance. For example, in an earlier study that 
aimed to determine the effects of a low dose of alcohol on driving performance, 
the BAC levels measured before and after a 70-min driving simulator session 
dropped from 25mg% to 13mg% (Vakulin et al., 2007). Another major limitation 
of oral dosing is that there are large individual differences in alcohol absorption, 
in which case many individuals have BAC levels that fall above or below the 
intended target value (see Figure 2). Both of the aforementioned limitations can 
be overcome by using the alcohol clamp method, as shown in the present study in 
which a steady BrAC was maintained in all study participants over a 2-hour 
period (see Figure 18). One of the disadvantages of the alcohol clamp method is 
that frequent breathalyzer measurements are needed initially, in order to adjust the 
infusion rate as needed to maintain the clamp at the prescribed BrAC level. Since 
we did not want the driving task to be interrupted by breathalyzer measurements, 
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it was timed near the end of the clamp procedure to ensure that the BrAC levels 
could be estimated reliably, i.e. after confirming that a stable clamp had been 
achieved. It should also be highlighted that the purpose of using the alcohol clamp 
method in this study was to examine the effects of a specific dose of alcohol on 
performance, but in the real-world the BrAC profile changes over time as alcohol 
is absorbed and metabolized. Therefore, oral dosing approaches are still important 
in approximating how driving simulator performance is influenced by alcohol 
consumption in real-world conditions. 
 
4.4 Limitations of the study 
This pilot study investigated the effects of alcohol on driving simulator 
performance during usual bedtime hours, but not at other time points. The 
rationale for studying driving performance at night is that the greatest proportion 
of alcohol-impaired driving crashes occurs during this time window. To compare 
the effects of both sleep loss and alcohol consumption and the possible synergistic 
effects between both factors, alcohol and placebo infusions would have to be 
administered when subjects are also well rested, something which was not 
examined in this present study design. It is possible that partial sleep loss 
enhances the effects of alcohol on driving performance, but this could only be 
evaluated by also comparing performance between alcohol and placebo during the 
daytime. In the present study, it also isn’t clear whether the degree of performance 
impairment caused by combining alcohol and partial sleep loss is similar to higher 
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doses of alcohol when individuals are rested. For example, it would be interesting 
to compare driving performance in the presence of a low dose of alcohol 
combined with sleep loss, versus performance at the legal BAC limit for operating 
a vehicle (80mg% in Singapore) in the absence of sleep loss.  
 
The ecological validity of research studies is almost always a limitation 
for laboratory-based data and studies. It cannot be known with certainty whether 
performance on the driving simulator correlates adequately with real-life driving 
behavior, as there is no risk of injury or death. Nonetheless, driving simulators 
have been used extensively for studying the effects of alcohol and sleep 
deprivation on driving behavior (Philip et al., 2005), as performance data can be 
collected safely and experimental conditions can be readily manipulated. Since 
subjects underwent a simulated night drive on a highway without vehicular traffic, 
it will also be important to study how driving performance is affected by alcohol 
and sleep loss in urban environments, as would be experienced in Singapore. 
Also, subjects were not allowed to consume caffeine prior to or during the study, 
whereas in the real-world it is common to take caffeine in an attempt to overcome 
sleepiness. Since only young healthy males were studied, in future studies it 
would be important to consider the effects of alcohol and sleep loss on females, 
and also in older populations who might respond differently to sleep deprivation 
and alcohol.  
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4.5 Future directions 
This study provides proof-of-concept that a low dose of alcohol can 
substantially impair driving performance during the late night hours when drivers 
are sleep deprived. It is important to extend the findings of the current study to 
evaluate the interaction of BrAC levels and time spent awake on driving 
performance. Using the alcohol clamp method, it should be possible to examine 
the dose-response for driving impairment at different BrAC levels, assessed for 
different levels of sleep deprivation. It would also be of interest to examine the 
effects of alcohol on attention and dual-task performance during simulated driving 
itself (Wester, Verster, Volkerts, Bocker, & Kenemans, 2010). Many in-car 
electronics are being implemented in modern cars and drivers sometimes perform 
a secondary task, like answering a phone call or simply reaching over to press a 
button to switch the radio channel. These actions can be potentially dangerous and 
contribute to accidents. It is also of interest to investigate driving behavior after a 
person has stopped consuming alcohol, as some studies have indicated that even 
after blood alcohol concentrations reach zero or near-undetectable levels, there 




CHAPTER 5. CONCLUSIONS 
The present study assessed the feasibility of using the alcohol clamp 
method to study the effects of alcohol and partial sleep loss on driving simulator 
performance. The findings indicate that the alcohol clamp is indeed a valid and 
reliable method in reaching and sustaining target BrAC levels over an extended 
period of time. I also found evidence that a low dose of alcohol (40mg% in saline) 
administered a few hours after usual bedtime results in greater deficits in driving 
simulator performance compared to a placebo. During alcohol infusion, subjective 
ratings of sleepiness and sedation in individuals were also elevated. Alcohol-
induced deficits in driving performance were comparable to an additional 2-4h of 
sleep loss without alcohol, as shown by the increase in amount of lane deviations. 
In conclusion, a low dose of alcohol at half the legal limit for drunk-driving in 
Singapore is sufficient to impair driving simulator performance during commonly 
faced levels of sleep loss. The information from this study can be potentially used 
to inform policies on what constitutes as a ‘safe BrAC’ for operating a vehicle 
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